| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/04/2014 | US20140248609 Gene detection assay for improving the likelihood of an effective response to an egfr antagonist cancer therapy |
| 09/04/2014 | US20140248372 Bone morphogenetic protein pathway activation, compositions for ossification, and methods related thereto |
| 09/04/2014 | US20140248365 Nanoparticle peptide compositions |
| 09/04/2014 | US20140248348 Use of salmonella flagellin derivative in preparation of drug for preventing and treating inflammatory bowel diseases |
| 09/04/2014 | US20140248339 Multi-component nanochains |
| 09/04/2014 | US20140248334 Peptides that target dorsal root ganglion neurons |
| 09/04/2014 | US20140248296 Sustained drug delivery system |
| 09/04/2014 | US20140248277 Multiple-variable dose regimen for treating tnfalpha-related disorders |
| 09/04/2014 | US20140248276 Multiple-variable dose regimen for treating tnfalpha-related disorders |
| 09/04/2014 | US20140248275 Multiple-variable dose regimen for treating tnfalpha-related disorders |
| 09/04/2014 | US20140248274 Stable lyophilized pharmaceutical preparations of monoclonal or polyclonal antibodies |
| 09/04/2014 | US20140248269 Medicinal agent for preventing exacerbation of malignant tumor, comprising combination of natriuretic peptide receptor gc-a and gc-b agonists |
| 09/04/2014 | US20140248260 Use of toll-like receptor agonist for treating cancer |
| 09/04/2014 | US20140248258 Methods for improving gut health |
| 09/04/2014 | US20140248257 Combination therapy for ischemia |
| 09/04/2014 | US20140248254 The use of ache as nuclease |
| 09/04/2014 | US20140248253 Compositions and methods for the treatment of cns injuries |
| 09/04/2014 | US20140248251 Methods and Pharmaceutical Compositions for Treating Celiac Disease and Gluten Intolerance |
| 09/04/2014 | US20140248250 Agent exhibiting bactericidal action with respect to vegetative and spore cells bacillus anthracis, anthrax preventing and treating method |
| 09/04/2014 | US20140248249 Method for stabilization and delivery of therapeutic molecules |
| 09/04/2014 | US20140248237 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases |
| 09/04/2014 | US20140248236 Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction |
| 09/04/2014 | US20140248235 Methods of Use for IL-22 Promoting Rejuvenation Of Thymic And Bone Marrow Function |
| 09/03/2014 | EP2772538A1 Polynucleotide encoding acyl-CoA synthetase homolog and method for using the same |
| 09/03/2014 | EP2772500A1 Site-directed modification of FVIII |
| 09/03/2014 | EP2772498A1 Polypeptides inhibiting neovascularization and uses thereof |
| 09/03/2014 | EP2772250A1 Enteric composition for the manufacture of soft capsule wall |
| 09/03/2014 | EP2772248A1 Pharmaceutical composition and kit for treating bacterial infections |
| 09/03/2014 | EP2771688A1 Free psa antibodies as diagnostics, prognostics and therapeutics for prostate cancer |
| 09/03/2014 | EP2771367A1 Gigaxonin fusion protein and methods for treating giant axonal neuropathy |
| 09/03/2014 | EP2771356A1 Chimeric molecule involving oligomerized fasl extracellular domain |
| 09/03/2014 | EP2771351A1 Pat-lm1 epitopes and methods for using same |
| 09/03/2014 | EP2771350A1 Topk peptides and vaccines including the same |
| 09/03/2014 | EP2771030A1 Compositions and methods for treatment of proteinopathies |
| 09/03/2014 | EP2771028A2 Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof |
| 09/03/2014 | EP2771027A1 Hemostatic compositions |
| 09/03/2014 | EP2771026A1 Ultra-concentrated rapid-acting insulin analogue formulations |
| 09/03/2014 | EP2771025A1 A polypeptide for the protection against heart ischemia-reperfusion injury |
| 09/03/2014 | EP2771024A1 Treatment protocol of diabetes type 2 |
| 09/03/2014 | EP2771023A1 Oral formulations mimetic of roux-en-y gastric bypass actions on the ileal brake; compositions, methods of treatment, diagnostics and systems for treatment of metabolic syndrome manifestations including insulin resistance, fatty liver disease, hyperlipidemia, and t2d |
| 09/03/2014 | EP2771022A2 Cd40l-specific tn3-derived scaffolds and methods of use thereof |
| 09/03/2014 | EP2771021A2 Nmda receptor modulators and uses thereof |
| 09/03/2014 | EP2771020A2 N-acyldipeptide derivatives and their uses |
| 09/03/2014 | EP2771017A1 A method of treating mucus hypersecretion |
| 09/03/2014 | EP2770853A1 Dietary product intended for the prevention of cardiometabolic risk |
| 09/03/2014 | EP2770852A1 Dietary product intended to reduce visceral fat during the pre-operative phase prior to bariatric surgery |
| 09/02/2014 | US8822656 Manufacture of factor H (FH) and FH-derivatives from plasma |
| 09/02/2014 | US8822654 Mutated antithrombins, a process for preparing the same and their use as drugs |
| 09/02/2014 | US8822646 Cancer therapies and pharmaceutical compositions used therein |
| 09/02/2014 | US8822643 Process for the preparation of a virus-inactivated FV concentrate starting from human plasma, scalable to industrial level |
| 09/02/2014 | US8822642 Dimeric fusion proteins and related compositions and methods |
| 09/02/2014 | US8822639 Transferrin fusion protein libraries |
| 09/02/2014 | US8822637 Somatostatin analogues |
| 09/02/2014 | US8822636 Peptides for activation and inhibition of δPKC |
| 09/02/2014 | US8822536 Dietary supplements containing terpenoid acids of maslinic acid or oleanolic acid and process for enhancing muscle mass in mammals |
| 09/02/2014 | US8822496 Dosage regimens for HCV combination therapy |
| 09/02/2014 | US8822493 SNS-595 and methods of using the same |
| 09/02/2014 | US8822442 Somatostatin-dopamine chimeric analogs |
| 09/02/2014 | US8822440 Inhibiting cyclin D polypeptides |
| 09/02/2014 | US8822423 Affinity peptides toward infliximab |
| 09/02/2014 | US8822422 Antitumor agent |
| 09/02/2014 | US8822421 E2F as a target of hormone refractory prostate cancer |
| 09/02/2014 | US8822420 Peptides and aptamers thereof as specific modulators of mutant p53 function |
| 09/02/2014 | US8822419 Membrane resident peptide in anti-cancer peptides causes tumor cell necrosis rather than apoptosis of cancer cells |
| 09/02/2014 | US8822418 Treatment of muscular dystrophies and related disorders |
| 09/02/2014 | US8822417 Albumin variants |
| 09/02/2014 | US8822416 Topical analgesic composition |
| 09/02/2014 | US8822415 Cellular-factor containing solution compositions |
| 09/02/2014 | US8822414 Heterocyclic compounds suitable for the treatment of dyslipidemia |
| 09/02/2014 | US8822413 Bifunctional hormone having alpha-MSH activity and natriuretic peptide activity and uses thereof |
| 09/02/2014 | US8822411 Truncated activin type II receptor and methods of use |
| 09/02/2014 | US8822410 Tympanic membrane permeating ear drops and uses thereof |
| 09/02/2014 | US8822409 Compositions and uses thereof for the treatment of acute respiratory distress syndrome (ARDS) and clinical disorders associated with therewith |
| 09/02/2014 | US8822408 Cell growth-promoting peptide and use thereof |
| 09/02/2014 | US8822407 Preparation of conjugates comprising adenine derivatives and allergenic proteins and their use for specific immunotherapy of allengenic diseases |
| 09/02/2014 | US8822406 Tumor activated prodrugs |
| 09/02/2014 | US8822405 Uses of mammalian cytokines and agonists; related reagents |
| 09/02/2014 | US8822194 Cancer selective auxotrophs |
| 09/02/2014 | US8822182 Chimeric antigen-specific T cell-activating polypeptides |
| 09/02/2014 | US8822179 Nucleic acid compositions and the encoding proteins |
| 09/02/2014 | US8822169 HMG1 antibody for treating inflammatory conditions |
| 09/02/2014 | US8822145 Identification of POLD2 sequences |
| 09/02/2014 | US8821943 Methods and compositions for targeted delivery of therapeutic agents |
| 09/02/2014 | US8821939 Bioactive agent delivery particles |
| 09/02/2014 | US8821925 Ubiquinol and alpha lipoic acid compositions |
| 09/02/2014 | US8821918 Cross-linked gelatin composition comprising a wetting agent |
| 09/02/2014 | US8821899 Method and process for the production of multi-coated recognitive and releasing systems |
| 09/02/2014 | US8821895 Streptococcus pyogenes antigens and corresponding DNA fragments |
| 09/02/2014 | US8821887 T-cell antigen peptide from allergen for stimulation of IL-10 production |
| 09/02/2014 | US8821883 Method of treating B cell cancers by administering truncated BAFF receptors |
| 09/02/2014 | US8821862 Soluble β-N-acetylglucosaminidase based antibiofilm compositions and uses thereof |
| 09/02/2014 | US8821861 Fibrin sealant |
| 09/02/2014 | US8821860 Targeted antimicrobials and related compositions, methods and systems |
| 09/02/2014 | US8821859 Methods and articles for the delivery of therapeutic agents |
| 09/02/2014 | US8821858 Lyophilized platelet rich plasma for the use in wound healing (chronic or acute) and bone or tissue grafts or repair |
| 09/02/2014 | US8821857 Human placental collagen compositions and methods of making and using the same |
| 09/02/2014 | US8821851 Inflammation-inhibitory serum factors and uses thereof |
| 09/02/2014 | US8821850 Protein-polymer-drug conjugates |
| 09/02/2014 | US8821533 Device for minimally invasive plastic surgery lift procedure |
| 09/02/2014 | CA2736974C Tumour-associated peptides that bind to mhc molecules |